from the end of the previous year. It was a result of a decrease in the temporary investment fund by Baht 4.91 million. The inventory increased by Baht 6.71 million. The advance payment of share and
13% to 13% and 20% yoy. It was driven by the outstanding profit for the Company and its subsidiary. In addition, the significant improvement of return on equity was from the decrease of shareholders
Performance (Income Statement) Q3.2018 Q3.2018 Increase/(decrease) % Income Income from Sale of Goods 140,004 151,554 (11,550) (7.62) Income from Sevice 81,443 - 81,443 100.00 Cost of Sale of Goods (108,549
tax assets 0.42 0.20 0.22 106.14 Total non-current assets 358.23 375.01 (16.78) (4.48) Details 31 Dec 2017 31 Dec 2016 Increase (Decrease) Percentage Total assets 729.13 561.39 167.74 29.88 Current
from 77.3 percent to 87.3 percent and Ms. Kanjana Pongpatanadecha’s shareholding proportion shall decrease from 18.7 percent to 8.7 percent. The Company is therefore obligated to comply with the
Approve decrease in registered capital Opinion of the Board of Directors The company’s board has a resolution to decrease the registered capital from 163,625,000 baht to 158,884,960.75 baht to cancel the
from Operating (CFO) 18.90 27.76 Cash Flow from Investing (CFI) 5.62 32.90 Cash Flow from Financing (CFF) (1.61) (6.53) Decrease in translation adjustments (0.18) 1.33 Net increase (decrease) in cash and
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
from Operating (CFO) 139.59 148.98 Cash Flow from Investing (CFI) (104.83) (48.88) Cash Flow from Financing (CFF) (52.68) (86.11) Decrease in translation adjustments (0.48) (2.33) Net increase (decrease